- Medtronic has received CE Mark for cardiac resynchronization therapy defibrillators approved for 3 Tesla magnetic resonance imaging scans
- “The ability to provide CRT-D patients with access to MRI scans is a significant, necessary advancement that may help save lives,” said Prof. J. Schwitter
Medtronic, a medical technology company based in Dublin, Ireland, has received CE Mark for cardiac resynchronization therapy defibrillators approved for 3 Tesla magnetic resonance imaging scans.
The approved devices include:
- Amplia MRI Quad CRT-D SureScan
- Claria MRI Quad CRT-D SureScan
- Compia MRI Quad CRT-D SureScan pacers
Also, all previously approved MRI-conditional cardiac implants can now be used in 3 Tesla magnetic resonance scanners in the region.
All three devices use Medtronic’s Attain Perfoma MRI SureScan Quadripolar leads that come in three sizes to fit different patients.
“The ability to provide CRT-D patients with access to MRI scans is a significant, necessary advancement that may help save lives,” said Prof. J. Schwitter, cardiologist and director of the Cardiac MR Center at the University Hospital Lausanne, Switzerland. “The most common magnetic field strength for an MRI is 1.5T, particularly for cardiac MRI; however, many institutions are installing 3T scanners to provide increased image clarity for conditions involving the brain and spine. With expanded access to 3T scans, physicians can now use a broader spectrum of MRI machines to most accurately diagnose critical and even life-threatening conditions.”
David Steinhaus, M.D., medical director for the Cardiac Rhythm and Heart Failure division of Medtronic, said “Medtronic is committed to providing patients with the most advanced MR-conditional technology available in cardiac rhythm and heart failure devices so they can have full access to essential MRI scans. With this latest regulatory milestone, Medtronic now provides both 1.5 and 3T MR-conditional pacemakers, ICMs, ICDs and CRT-Ds in Europe.”
Visit the source page: Medtronic